農發種業(600313.SH):實控人一致行動人華農資產增持0.61%股份
格隆匯11月4日丨農發種業(600313.SH)公佈,2019年11月4日,公司收到實際控制人之一致行動人華農資產的通知,2019年10月30日至2019年11月4日期間,華農資產通過上海證券交易所交易系統已累計增持公司股份658.1160萬股,佔公司總股本的0.61%。
截止2019年11月4日,中國農發集團及其一致行動人合計持有農發種業4.1455億股股份,合計持股比例為38.31%。其中:中國農發集團、中國農墾集團有限公司持有公司股份的數量和比例未變動,華農資產持有農發種業658.1160萬股股份,持股比例為0.61%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.